540694 — ANG Lifesciences India Share Price
0.000.00%
Last trade - 00:00- IN₹364.33m
- IN₹1.07bn
- IN₹1.46bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.51 | ||
| Price to Tang. Book | 0.51 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.32 | ||
| EV to EBITDA | 2,017.21 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -8.37% | ||
| Return on Equity | -17.84% | ||
| Operating Margin | -6.44% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 1,268.31 | 1,543.79 | 3,543.02 | 2,198.91 | 1,461.1 | n/a | n/a | 3.72% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +6.99 | +15.28 | +474.83 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packaging. The Company's product portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. The Company’s product category includes Dry Powder Injection, Liquid Injections, Hard Gelatin Capsule, Tablet Beta Lactum, Tablets, Liquid Suspension /Syrup, Ointment/Creams, and Soft Gelatin Capsule. Its Dry Powder Injection products include Ampicillin & Cloxacillin for injection 500mg, Azetronam for Injection USP 500mg, Ampicillin Injection 1.0gm, Ceftriaxone Injection 250mg, Amoxycillin & Potassium Clavulanate for injection 1.2gm, and others.
Directors
- Subodh Sharma CFO (58)
- Renu Kaur CCO
- Rajesh Gupta MDR (46)
- Sudesh Kumari NED (71)
- Pawanjit Singh IND (51)
- Chetna .. NID
- Sukhpal Singh NID (43)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 14th, 2006
- Public Since
- September 8th, 2017
- No. of Shareholders
- 7,035
- No. of Employees
- 433
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 13,058,287
- Address
- SCO 113, 1st Floor, Darbara Complex, AMRITSAR, 143001
- Web
- https://anglifesciences.com/
- Phone
- +91 1835070118
- Auditors
- Singh Bhupinder & Associates
Upcoming Events for 540694
Q1 2026 ANG Lifesciences India Ltd Earnings Release
ANG Lifesciences India Ltd Annual Shareholders Meeting
Similar to 540694
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the ANG Lifesciences India share price?
As of Today at 19:16 UTC, shares in ANG Lifesciences India are trading at IN₹27.90. This share price information is delayed by 15 minutes.
How has the ANG Lifesciences India share price performed this year?
Shares in ANG Lifesciences India last closed at IN₹27.90 and the price had moved by -50.61% over the past 365 days. In terms of relative price strength the ANG Lifesciences India share price has underperformed the S&P BSE 100 Index by -54.3% over the past year.
What are the analyst and broker recommendations for ANG Lifesciences India?
There is no consensus recommendation for this security.
Find out moreWhat is the ANG Lifesciences India dividend yield?
ANG Lifesciences India does not currently pay a dividend.
Does ANG Lifesciences India pay a dividend?
ANG Lifesciences India does not currently pay a dividend.
When does ANG Lifesciences India next pay dividends?
ANG Lifesciences India does not currently pay a dividend.
How do I buy ANG Lifesciences India shares?
To buy shares in ANG Lifesciences India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of ANG Lifesciences India?
As of the previous close price of IN₹27.90, shares in ANG Lifesciences India had a market capitalisation of IN₹364.33m.
Where are ANG Lifesciences India shares listed?
Here are the trading details for ANG Lifesciences India:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 540694
What kind of share is ANG Lifesciences India?
Based on an overall assessment of its quality, value and momentum ANG Lifesciences India is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a ANG Lifesciences India share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the ANG Lifesciences India share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ANG Lifesciences India. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -40.82%.
As of the last closing price of IN₹27.90, shares in ANG Lifesciences India were trading -36.49% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the ANG Lifesciences India PE Ratio?
The ANG Lifesciences India PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹27.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of ANG Lifesciences India?
ANG Lifesciences India's management team is headed by:
- Subodh Sharma - CFO
- Renu Kaur - CCO
- Rajesh Gupta - MDR
- Sudesh Kumari - NED
- Pawanjit Singh - IND
- Chetna .. - NID
- Sukhpal Singh - NID